Safety of Direct Administration of AAV2 CU hCLN2, a Candidate Treatment for the Central Nervous System Manifestations of Late Infantile Neuronal Ceroid Lipofuscinosis, to the Brain of Rats and Nonhuman Primates
Hackett, Neil R., Redmond, D. Eugene, Sondhi, Dolan, Giannaris, E. Lela, Vassallo, Elizabeth, Stratton, Jamie, Qiu, Jianping, Kaminsky, Stephen M., Lesser, Martin L., Fisch, Gene S., Rouselle, Serge DVolume:
16
Langue:
english
Journal:
Human Gene Therapy
DOI:
10.1089/hum.2005.16.1484
Date:
December, 2005
Fichier:
PDF, 1.00 MB
english, 2005
File converter
Plus de résultats de recherche
More benefits 
